Abstract
Background and PurposeOxotremorine (OXO) is a cholinergic agonist that increases cerebral blood flow (CBF) when administered intravenously. We tested the hypothesis that OXO causes a dose-related increase in CBF in cats via a muscarinic mechanism that involves stimulation of nitric oxide synthase.
Original language | English (US) |
---|---|
Pages (from-to) | 2160-2165 |
Number of pages | 6 |
Journal | Stroke |
Volume | 26 |
Issue number | 11 |
DOIs | |
State | Published - Nov 1995 |
Externally published | Yes |
ASJC Scopus subject areas
- Clinical Neurology
- Cardiology and Cardiovascular Medicine
- Advanced and Specialized Nursing